Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA’s public hospitals.
Insulin deal faces criticism over lack of insulin pens
Original Article by Christina Pitt | Bhekisisa Centre for Health Journalism | 16 August 2025
Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA's public hospitals.
More Posts
Dis-Chem succession enters a new phase
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
Read more...
Ectopic pregnancy deaths expose care gaps
Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.
Read more...
Childhood immunisation coverage falls sharply in SA
Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.
Read more...